Tektology joins InGeNA

Tektology joins InGeNA

InGeNA welcomes Tektology as a new member.  Read more about Tektology here and on their website: Tektology is an international health innovation & strategy consultancy headquartered in the UK and with offices in Australia, Saudi Arabia, and India. We are senior...
Gene S joins InGeNA

Gene S joins InGeNA

InGeNA welcomes Gene S as a new member.  Read more about Gene S here and on their website: Gene S is a Western Australian company with a groundbreaking pharmacogenomic technology platform. Gene S’s PGx solution, featuring advanced genetic testing and reporting...
Genomical joins InGeNA

Genomical joins InGeNA

InGeNA welcomes Genomical® as a new member.  Read more about Genomical® here and on their website: New venture to support Genomical® in the sustainability and scale-up of clinical genomic testing Transcendomics is a new spinout company from the Melbourne Genomics...
InGeNA CEO Annoucement

InGeNA CEO Annoucement

The InGeNA Board is thrilled to announce Erin Evans as the incoming CEO, beginning her tenure in July 2024. Erin brings a wealth of experience and a track record of success, having served as CEO of Life Sciences Qld, where she spearheaded transformative initiatives...
MGI joins InGeNA

MGI joins InGeNA

InGeNA welcomes MGI as a new member.  Read more about MGI here and on their website: MGI Tech Co., Ltd. (or its subsidiaries, together referred to MGI), headquartered in Shenzhen, is committed to building core tools and technology to lead life science through...
SydPath joins InGeNA

SydPath joins InGeNA

InGeNA welcomes SydPath Pathology as a new member.  Read about the great work that SydPath does here and on their website: SydPath provides purpose driven, personalised pathology with an unwavering commitment to delivering high quality tests with a fast time to...